In terms of revenue, the global radiopharmaceutical theragnostic market was valued at US$ 1123.42 Mn in 2020 and is projected to grow at a CAGR of 15.83% over the forecast period (2021 – 2030). An informative report titled as Radiopharmaceutical Theragnostic Market recently has been published by Absolute Markets Insights. This measurable information offers a top to bottom investigation by thinking about a few fragments, like sort, size, innovation and applications. Diverse exploratory procedures, for example, subjective and quantitative investigation have been utilized to give information precisely. For better comprehension of the clients, it utilizes powerful graphical show procedures, like diagrams, outlines, tables just as pictures.

Some of key players operating in the global radiopharmaceutical theragnostic market are Advanced Accelerator Applications, A Novartis Company, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical Imaging, Inc., NanoMab, NuView Life Sciences, PentixaPharm GmbH, Precirix, RadioMedix, RayzeBio, Telix Pharmaceuticals Limited, Theragnostics Ltd and Vect-Horus, amongst others.

Read More on Radiopharmaceutical Theragnostic Market Report:

Increasing demand for targeted destruction of cancer cells, along with faster diagnostics of cancer, is expected to drive the growth of the global radiopharmaceutical theragnostic market in the coming years. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries. The Global Radiopharmaceutical Theragnostic Market Report incorporates the precisely contemplated and surveyed information of the key business players and their extension in the market through various scientific devices.

The scientific devices, for example, Porter's five powers investigation, SWOT examination, possibility study, and venture return examination have been utilized to break down the development of the central participants working on the lookout. This research report includes the assessment of key market features, such as revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. This research report also offers a comprehensive study of the key market dynamics and existing trends, market segments and sub-segments.

Global Radiopharmaceutical Theragnostic Market

By Clinical Trial Phase

  • Phase I
  • Phase II
  • Phase III

By Application

  • Thyroid cancer
  • Brain cancer
  • Lymphoma
  • Others

By Route of Administration

  • Oral
  • Intravenous
  • Interstitial

By End-Users

  • Hospitals and Clinics
  • Pharmaceutical Companies
  • Research Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Contact Us:

Company: Absolute Markets Insights

Email Id:

Phone: IN +917400242424, US +1-510-420-1213

Contact Name: Shreyas Tanna